Swedbank AB Sells 77,882 Shares of Cencora, Inc. $COR

Swedbank AB lessened its holdings in shares of Cencora, Inc. (NYSE:COR) by 11.6% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 594,663 shares of the company’s stock after selling 77,882 shares during the period. Swedbank AB’s holdings in Cencora were worth $186,807,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of COR. Kemnay Advisory Services Inc. acquired a new position in Cencora during the 4th quarter worth about $25,000. Oakworth Capital Inc. bought a new stake in shares of Cencora in the 4th quarter valued at about $26,000. Elyxium Wealth LLC acquired a new stake in shares of Cencora in the fourth quarter valued at about $27,000. Archer Investment Corp raised its position in shares of Cencora by 134.3% during the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after acquiring an additional 47 shares during the last quarter. Finally, Motiv8 Investments LLC bought a new position in shares of Cencora during the fourth quarter worth about $29,000. Institutional investors own 97.52% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on COR. Robert W. Baird reduced their target price on Cencora from $420.00 to $339.00 and set an “outperform” rating on the stock in a report on Thursday, May 7th. Barclays lowered their price target on shares of Cencora from $425.00 to $350.00 and set an “overweight” rating for the company in a report on Wednesday, June 10th. William Blair began coverage on shares of Cencora in a research report on Tuesday, April 28th. They issued a “market perform” rating on the stock. Bank of America upped their price objective on shares of Cencora from $280.00 to $285.00 and gave the company a “neutral” rating in a research note on Wednesday, June 24th. Finally, Citigroup decreased their price objective on shares of Cencora from $405.00 to $355.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. Eleven investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $367.75.

Cencora Stock Up 2.8%

NYSE:COR traded up $8.31 during trading hours on Tuesday, reaching $306.86. The company had a trading volume of 446,864 shares, compared to its average volume of 1,545,545. Cencora, Inc. has a twelve month low of $244.82 and a twelve month high of $377.54. The company has a quick ratio of 0.59, a current ratio of 0.95 and a debt-to-equity ratio of 3.40. The firm has a market cap of $59.70 billion, a price-to-earnings ratio of 23.53, a P/E/G ratio of 1.65 and a beta of 0.58. The business’s 50-day simple moving average is $277.66 and its two-hundred day simple moving average is $319.86.

Cencora (NYSE:COR) last issued its earnings results on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing the consensus estimate of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The firm had revenue of $78.36 billion during the quarter, compared to analyst estimates of $81.09 billion. During the same quarter in the prior year, the business earned $4.42 earnings per share. The business’s quarterly revenue was up 3.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, equities analysts expect that Cencora, Inc. will post 17.79 earnings per share for the current year.

Cencora Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were issued a $0.60 dividend. The ex-dividend date was Friday, May 15th. This represents a $2.40 annualized dividend and a yield of 0.8%. Cencora’s dividend payout ratio is presently 18.40%.

Cencora announced that its board has initiated a stock repurchase plan on Thursday, May 21st that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the company to reacquire up to 3.9% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s management believes its stock is undervalued.

Insider Buying and Selling

In other news, Director Lauren M. Tyler acquired 550 shares of the firm’s stock in a transaction dated Monday, June 22nd. The stock was purchased at an average price of $270.23 per share, for a total transaction of $148,626.50. Following the completion of the acquisition, the director directly owned 4,359 shares in the company, valued at $1,177,932.57. The trade was a 14.44% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 0.38% of the company’s stock.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.